Zhao, J. et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. BMJ Oncol. 2, (2023).

Ben-Aharon, I. et al. Early-onset cancer in the gastrointestinal tract is on the rise-evidence and implications. Cancer Discov 13, 538–551 (2023).

Article  CAS  PubMed  Google Scholar 

Ben-Aharon, I. et al. Pharmaceutical agents as potential drivers in the development of early-onset colorectal cancer: case-control study. JMIR Public Health Surveill 9, e50110 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Tian, R. et al. Rising accelerated aging in recent generations associated with elevated risk of early-onset cancers. In AACR Annual Meeting 2024 Abstract 846/19 (2024).

Laskar, R. S. et al. Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancer. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 35, 523–536 (2024).

Article  CAS  Google Scholar 

John, T. D., Sender, L. S. & Bota, D. A. Cognitive impairment in survivors of adolescent and early young adult onset non-CNS cancers: does chemotherapy play a role? J. Adolesc. Young Adult Oncol. 5, 226–231 (2016).

Article  PubMed  Google Scholar 

Ganz, P. A., Greendale, G. A., Petersen, L., Kahn, B. & Bower, J. E. Breast cancer in younger women: reproductive and late health effects of treatment. J. Clin. Oncol. 21, 4184–4193 (2003).

Article  PubMed  Google Scholar 

Sella, T. et al. Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors. Cancer 127, 2888–2894 (2021).

Article  CAS  PubMed  Google Scholar 

Quinn, G. P. et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J. Clin. Oncol. 27, 5952–5957 (2009).

Article  PubMed  Google Scholar 

Ben-Aharon, I. et al. Social networks for young patients with cancer: the time for system agility. Lancet Oncol 20, 765 (2019).

Article  PubMed  Google Scholar 

Fontana, E. et al. Early-onset colorectal adenocarcinoma in the idea database: treatment adherence, toxicities, and outcomes with 3 and 6 months of adjuvant fluoropyrimidine and oxaliplatin. J. Clin. Oncol. 36, 4009–4019 (2021).

Article  Google Scholar